BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 32949235)

  • 21. Role of thiopurine and anti-TNF therapy in lymphoma in inflammatory bowel disease.
    Herrinton LJ; Liu L; Weng X; Lewis JD; Hutfless S; Allison JE
    Am J Gastroenterol; 2011 Dec; 106(12):2146-53. PubMed ID: 22031357
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Presence of a high-grade component in gastric mucosa-associated lymphoid tissue (MALT) lymphoma is not associated with an adverse prognosis.
    Ang MK; Hee SW; Quek R; Yap SP; Loong S; Tan L; Tao M; Lim ST
    Ann Hematol; 2009 May; 88(5):417-24. PubMed ID: 18777110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Lymphoproliferative Disorders in Inflammatory Bowel Disease Patients: Is It the Drugs or the Disease.
    Bernardes C; Russo P; Carvalho D; Saiote J; Ramos J
    GE Port J Gastroenterol; 2018 Jun; 25(4):175-178. PubMed ID: 29998162
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extra-intestinal malignancies in inflammatory bowel disease: results of the 3rd ECCO Pathogenesis Scientific Workshop (III).
    Magro F; Peyrin-Biroulet L; Sokol H; Aldeger X; Costa A; Higgins PD; Joyce JC; Katsanos KH; Lopez A; de Xaxars TM; Toader E; Beaugerie L
    J Crohns Colitis; 2014 Jan; 8(1):31-44. PubMed ID: 23721759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Primary non-Hodgkin's lymphoma of the intestine: high prevalence of Epstein-Barr virus in Mexican lymphomas as compared with European cases.
    Quintanilla-Martínez L; Lome-Maldonado C; Ott G; Gschwendtner A; Gredler E; Reyes E; Angeles-Angeles A; Fend F
    Blood; 1997 Jan; 89(2):644-51. PubMed ID: 9002968
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of Epstein-Barr virus serological status on clinical outcomes in adult patients with inflammatory bowel disease.
    de Francisco R; Castaño-García A; Martínez-González S; Pérez-Martínez I; González-Huerta AJ; Morais LR; Fernández-García MS; Jiménez S; Díaz-Coto S; Flórez-Díez P; Suárez A; Riestra S
    Aliment Pharmacol Ther; 2018 Oct; 48(7):723-730. PubMed ID: 30095176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prognosis of Lymphoma in Patients With Known Inflammatory Bowel Disease: A French Multicentre Cohort Study.
    Severyns T; Kirchgesner J; Lambert J; Thieblemont C; Amiot A; Abitbol V; Treton X; Cazals-Hatem D; Malamut G; Coppo P; Galicier L; Walter-Petrich A; Deau-Fischer B; Besson C; Aparicio T; Beaugerie L; Allez M; Gornet JM
    J Crohns Colitis; 2020 Sep; 14(9):1222-1230. PubMed ID: 32161943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epstein-barr virus-positive diffuse large B-cell lymphoma of the elderly: what we know so far.
    Castillo JJ; Beltran BE; Miranda RN; Paydas S; Winer ES; Butera JN
    Oncologist; 2011; 16(1):87-96. PubMed ID: 21212426
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A20 (TNFAIP3) deletion in Epstein-Barr virus-associated lymphoproliferative disorders/lymphomas.
    Ando M; Sato Y; Takata K; Nomoto J; Nakamura S; Ohshima K; Takeuchi T; Orita Y; Kobayashi Y; Yoshino T
    PLoS One; 2013; 8(2):e56741. PubMed ID: 23418597
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Natural killer cell lymphoma in a pediatric patient with inflammatory bowel disease.
    Deneau M; Wallentine J; Guthery S; O'Gorman M; Bohnsack J; Fluchel M; Bezzant J; Pohl JF
    Pediatrics; 2010 Oct; 126(4):e977-81. PubMed ID: 20837584
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Inflammatory bowel diseases and lymphoma].
    Karoui S; Boubaker J; Filali A
    Tunis Med; 2004 Feb; 82(2):185-9. PubMed ID: 15185593
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Non-hodgkin's lymphomas].
    Drouet F; Cahu X; Pointreau Y; Denis F; Mahé MA
    Cancer Radiother; 2010 Nov; 14 Suppl 1():S210-29. PubMed ID: 21129666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Clinical and pathological reassessment of 493 cases of non-Hodgkin's lymphomas according to current WHO classification of lymphoid neoplasms].
    Xiao C; Su ZL; Wu QL; Gao HY; Fang JC; Xia ZJ; Guan ZZ
    Zhonghua Bing Li Xue Za Zhi; 2005 Jan; 34(1):22-7. PubMed ID: 15796877
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epstein-Barr virus genome in non-Hodgkin's lymphomas occurring in immunocompetent patients: highest prevalence in nonlymphoblastic T-cell lymphoma and correlation with a poor prognosis. Danish Lymphoma Study Group, LYFO.
    d'Amore F; Johansen P; Houmand A; Weisenburger DD; Mortensen LS
    Blood; 1996 Feb; 87(3):1045-55. PubMed ID: 8562929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IBD-related carcinoma and lymphoma.
    Claessen MM; Siersema PD; Vleggaar FP
    Best Pract Res Clin Gastroenterol; 2011 Apr; 25 Suppl 1():S27-38. PubMed ID: 21640928
    [TBL] [Abstract][Full Text] [Related]  

  • 36. AIDS-related lymphoma in Brazil. Histopathology, immunophenotype, and association with Epstein-Barr virus.
    Bacchi CE; Bacchi MM; Rabenhorst SH; Soares FA; Fonseca LE; Barbosa HS; Weiss LM; Gown AM
    Am J Clin Pathol; 1996 Feb; 105(2):230-7. PubMed ID: 8607450
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epstein-Barr virus related lymphoma in inflammatory bowel disease.
    Van Biervliet S; Velde SV; De Bruyne R; De Looze D; De Vos M; Van Winckel M
    Acta Gastroenterol Belg; 2008; 71(1):33-5. PubMed ID: 18396748
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multicenter retrospective analysis of 581 patients with primary intestinal non-hodgkin lymphoma from the Consortium for Improving Survival of Lymphoma (CISL).
    Kim SJ; Choi CW; Mun YC; Oh SY; Kang HJ; Lee SI; Won JH; Kim MK; Kwon JH; Kim JS; Kwak JY; Kwon JM; Hwang IG; Kim HJ; Lee JH; Oh S; Park KW; Suh C; Kim WS
    BMC Cancer; 2011 Jul; 11():321. PubMed ID: 21798075
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cancer Risk in Inflammatory Bowel Disease: A 6-Year Prospective Multicenter Nested Case-Control IG-IBD Study.
    Biancone L; Armuzzi A; Scribano ML; Castiglione F; D'Incà R; Orlando A; Papi C; Daperno M; Vecchi M; Riegler G; Fries W; Alvisi P; Meucci G; Mocciaro F; Rogai F; Festa S; Guidi L; Testa A; Spina L; Renna S; Viola A; Patturelli M; Di Mitri R; Frankovic I; Calabrese E; Petruzziello C; De Cristofaro E; Sena G; Ruffa A; Neri B; Rossi A
    Inflamm Bowel Dis; 2020 Feb; 26(3):450-459. PubMed ID: 31498388
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Anti-TNFα therapy for inflammatory bowel diseases is associated with Epstein-Barr virus lytic activation.
    Lapsia S; Koganti S; Spadaro S; Rajapakse R; Chawla A; Bhaduri-McIntosh S
    J Med Virol; 2016 Feb; 88(2):312-8. PubMed ID: 26307954
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.